Authors: DEMETER LM MEEHAN PM MORSE G FISCHL MA PARA M POWDERLY W LEEDOM J HOLDENWILTSE J GREISBERGER C WOOD K TIMPONE J WATHEN LK NEVIN T RESNICK L BATTS DH REICHMAN RC

Citation: Lm. Demeter et al., PHASE-I STUDY OF ATEVIRDINE MESYLATE (U-87201E) MONOTHERAPY IN HIV-1-INFECTED PATIENTS, Journal of acquired immune deficiency syndromes and human retrovirology, 19(2), 1998, pp. 135-144

Authors: FISCHL MA RICHMAN DD SAAG M MENG TC SQUIRES KE HOLDENWILTSE J MEEHAN PM

Citation: Ma. Fischl et al., SAFETY AND ANTIVIRAL ACTIVITY OF COMBINATION THERAPY WITH ZIDOVUDINE,ZALCITABINE, AND 2 DOSES OF INTERFERON-ALPHA(2A) IN PATIENTS WITH HIV- AIDS CLINICAL-TRIALS GROUP-STUDY-197, Journal of acquired immune deficiency syndromes and human retrovirology, 16(4), 1997, pp. 247-253

Authors: FISCHL MA RICHMAN DD FLEXNER C PARA MF HAUBRICH R KARIM A YERAMIAN P HOLDENWILTSE J MEEHAN PM

Citation: Ma. Fischl et al., PHASE I II STUDY OF THE TOXICITY, PHARMACOKINETICS, AND ACTIVITY OF THE HIV PROTEASE INHIBITOR SC-52151/, Journal of acquired immune deficiency syndromes and human retrovirology, 15(1), 1997, pp. 28-34

Authors: DEMETER LM MEEHAN PM MORSE G GERONDELIS P DEXTER A BERRIOS L COX S FREIMUTH W REICHMAN RC

Citation: Lm. Demeter et al., HIV-1 DRUG SUSCEPTIBILITIES AND REVERSE-TRANSCRIPTASE MUTATIONS IN PATIENTS RECEIVING COMBINATION THERAPY WITH DIDANOSINE AND DELAVIRIDINE, Journal of acquired immune deficiency syndromes and human retrovirology, 14(2), 1997, pp. 136-144

Authors: JAPOUR AJ LERTORA JJ MEEHAN PM ERICE A CONNOR JD GRIFFITH BP CLAX PA HOLDENWILTSE J HUSSEY S WALESKY M COONEY E POLLARD R TIMPONE J MCLAREN C JOHANNESON N WOOD K BOOTH DK BASSIAKOS Y CRUMPACKER CS

Citation: Aj. Japour et al., A PHASE-I STUDY OF THE SAFETY, PHARMACOKINETICS, AND ANTIVIRAL ACTIVITY OF COMBINATION DIDANOSINE AND RIBAVIRIN IN PATIENTS WITH HIV-1 DISEASE, Journal of acquired immune deficiency syndromes and human retrovirology, 13(3), 1996, pp. 235-246

Authors: REICHMAN RC MORSE GD DEMETER LM RESNICK L BASSIAKOS Y FISCHL M PARA M POWDERLY W LEEDOM J GREISBERGER C NEVIN T WOOD K MEEHAN PM GEHEB H COX S BATTS D TIMPONE J SLACK A ROYAL M QUESADA NR GEISELER PJ STARK N NEIDIG J HILL M

Citation: Rc. Reichman et al., PHASE-I STUDY OF ATEVIRDINE, A NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR, IN COMBINATION WITH ZIDOVUDINE FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION, The Journal of infectious diseases, 171(2), 1995, pp. 297-304